Peripheral Artery Disease Market by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories): Global Opportunity Analysis and Industry Forecast, 2020–2027
The global peripheral artery disease market accounted for $3,524.77 million in 2019, and is expected to reach $5,715.12 million by 2027, registering a CAGR of 8.5% from 2020 to 2027.
Peripheral artery disease (PAD) is a disease of blood vessels located outside the brain and heart. PAD occurs when plaque builds up in arteries that carry blood to the head, organs, and limbs. Plaque is made of fat, cholesterol, calcium, fibrous tissue, and other substances. PAD usually affects arteries in the legs, but it can also affect arteries that carry blood from heart to head, arms, kidneys, and stomach.
Factors such as rapid growth in geriatric population and subsequent increase in prevalence of peripheral artery diseases, along with increase in product approvals drive growth of the peripheral artery disease market. However, product recalls and hamper the market growth. Furthermore, increase in incidences of population suffering from diabetes and high blood pressure, which poses a high-risk factor for peripheral artery disease drives the market growth. In addition, favorable reimbursement scenario for peripheral artery disease treatment and introduction of advanced treatment products such as drug-eluting stents boost the market growth. However, issue of restenosis (reoccurrence of peripheral artery disease even after treatment) impedes the market growth.
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped & better financed hospitals & clinics, high adoption rate of peripheral artery disease products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness regarding PAD devices. However, Asia-Pacific and LAMEA are expected to emerge as a lucrative areas with maximum growth potential, owing to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.
The global peripheral artery disease market is segmented on the basis of type and region. On the basis of type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, the market is studied across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, India, China, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA)
The key companies operating in the market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Cardinal Health, Inc., Becton, Dickinson and Company, Terumo Corporation, Koninklijke Philips N.V, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG.
KEY BENEFITS FOR STAKEHOLDERS
By type
North America
Peripheral artery disease (PAD) is a disease of blood vessels located outside the brain and heart. PAD occurs when plaque builds up in arteries that carry blood to the head, organs, and limbs. Plaque is made of fat, cholesterol, calcium, fibrous tissue, and other substances. PAD usually affects arteries in the legs, but it can also affect arteries that carry blood from heart to head, arms, kidneys, and stomach.
Factors such as rapid growth in geriatric population and subsequent increase in prevalence of peripheral artery diseases, along with increase in product approvals drive growth of the peripheral artery disease market. However, product recalls and hamper the market growth. Furthermore, increase in incidences of population suffering from diabetes and high blood pressure, which poses a high-risk factor for peripheral artery disease drives the market growth. In addition, favorable reimbursement scenario for peripheral artery disease treatment and introduction of advanced treatment products such as drug-eluting stents boost the market growth. However, issue of restenosis (reoccurrence of peripheral artery disease even after treatment) impedes the market growth.
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped & better financed hospitals & clinics, high adoption rate of peripheral artery disease products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness regarding PAD devices. However, Asia-Pacific and LAMEA are expected to emerge as a lucrative areas with maximum growth potential, owing to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.
The global peripheral artery disease market is segmented on the basis of type and region. On the basis of type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, the market is studied across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, India, China, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA)
The key companies operating in the market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Cardinal Health, Inc., Becton, Dickinson and Company, Terumo Corporation, Koninklijke Philips N.V, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
- The key market players and their strategies have been analyzed to understand the competitive outlook of the market.
By type
- Peripheral Angioplasty Balloons
- Old/Normal Balloons
- Cutting and Scoring Balloons
- Drug-Coated Balloons
- Peripheral Stents
- Self-expandable
- Balloon-expandable
- Covered
- Drug-eluting Stents
- Peripheral Catheters
- Angiography Catheters
- Guiding Catheters
- Inferior Vena Cava (IVC) Filters
- Permanent Filters
- Retrievable Filters
- Plaque Modification Devices
- Thrombectomy Devices
- Mechanical Thrombectomy Devices
- Aspiration Thrombectomy Devices
- Rheolytic Thrombectomy Devices
- Atherectomy Devices
- Hemodynamic Flow Alteration Devices
- Embolic Protection Devices
- Chronic Total Occlusion Devices
- Peripheral Accessories
- Vascular Closure Devices
- Introducer Sheaths
- Guidewires
- Balloon Inflation Devices
North America
- U.S.
- Canada
- Mexico
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- AngioDynamics
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- BIOTRONIK
- Cook Medical
- Cardinal Health, Inc.
- Koninklijke Philips N.V
- TERUMO CORPORATION.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top winning strategies, 2019
3.3.Top player positioning
3.3.1.Top investment pockets
3.4.Key forces shaping peripheral artery disease industry/market
3.4.1.Drivers
3.4.1.1.Growth in geriatric population and increase in prevalence of peripheral artery disease
3.4.1.2.Introduction of advanced interventional products
3.4.1.3.Improvement of healthcare infrastructure in developing countries
3.4.1.4.Improved insurance and reimbursement policies
3.4.2.Restraints
3.4.2.1.Restenosis
3.4.2.2.Stringent approval process for stents
3.4.3.Opportunity
3.4.3.1.Market opportunities in developing countries
3.4.4.Impact Analysis
3.5.COVID-19 impact on the market
CHAPTER 4:PERIPHERAL ARTERY DISEASE MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast, by type
4.2.Peripheral Angioplasty Balloons
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Peripheral angioplasty balloons, by type
4.2.4.1.Market size and forecast
4.2.4.2.Old/normal balloons, market size and forecast
4.2.4.3.Cutting & scoring balloons, market size and forecast
4.2.4.4.Drug-coated balloons, market size and forecast
4.3.Peripheral Stents
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Peripheral stent, by type
4.3.4.1.Market size and forecast
4.3.4.2.Self-expandable, market size and forecast
4.3.4.3.Balloon-expandable, market size and forecast
4.3.4.4.Covered stents, market size and forecast
4.3.4.5.Drug-eluting stents, market size and forecast
4.4.Peripheral Catheters
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Peripheral catheters, by type
4.4.4.1.Market size and forecast
4.4.4.2.Angiography catheters, market size and forecast
4.4.4.3.Guiding catheters, market size and forecast
4.5.Inferior Vena Cava (IVC) Filters
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.5.4.Inferior vena cava (IVC) filters, by type
4.5.4.1.Market size and forecast
4.5.4.2.Permanent filters, market size and forecast
4.5.4.3.Retrievable filters, market size and forecast
4.6.Plaque Modification Devices
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
4.6.4.Plaque modification devices, by type
4.6.4.1.Market size and forecast
4.6.4.2.Thrombectomy devices, market size and forecast
4.6.4.3.Thrombectomy devices, By type
4.6.4.4.Thrombectomy devices, market size and forecast, by type
4.6.4.4.1.Mechanical thrombectomy devices, market size and forecast
4.6.4.4.2.Aspiration thrombectomy devices, market size and forecast
4.6.4.4.3.Rheolytic thrombectomy devices, market size and forecast
4.6.4.5.Atherectomy devices, market size and forecast
4.7.Hemodynamic Flow Alteration Devices
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market analysis, by country
4.7.4.Hemodynamic flow alteration devices, By type
4.7.4.1.Market size and forecast
4.7.4.2.Embolic protection devices, market size and forecast
4.7.4.3.Chronic total occlusion devices, market size and forecast
4.8.Peripheral Accessories
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.8.3.Market analysis, by country
4.8.4.Peripheral Accessories, By type
4.8.4.1.Market size and forecast
4.8.4.2.Peripheral vascular closure devices, market size and forecast
4.8.4.3.Introducer sheaths, market size and forecast
4.8.4.4.Guidewires, market size and forecast
4.8.4.5.Balloon inflation devices, market size and forecast
CHAPTER 5:PERIPHERAL ARTERY DISEASE MARKET, BY REGION
5.1.Overview
5.1.1.Market size and forecast, by region
5.2.North America
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country
5.2.3.Market size and forecast, by type
5.2.4.U.S.
5.2.5.Canada
5.2.6.Mexico
5.3.Europe
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country
5.3.3.Market size and forecast, by type
5.3.4.Germany
5.3.5.France
5.3.6.UK
5.3.7.Italy
5.3.8.Spain
5.3.9.Rest of Europe
5.4.Asia-Pacific
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country
5.4.3.Market size and forecast, by type
5.4.4.Japan
5.4.5.China
5.4.6.India
5.4.7.Australia
5.4.8.Rest of Asia-Pacific
5.5.LAMEA
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country
5.5.3.Market size and forecast, by type
5.5.4.Brazil
5.5.5.South Africa
5.5.6.Saudi Arabia
5.5.7.Rest of LAMEA
CHAPTER 6:COMPANY PROFILES
6.1.ABBOTT LABORATORIES
6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.2.ANGIODYNAMICS, INC.
6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.2.6.Key strategic moves and developments
6.3.B. BRAUN MELSUNGEN AG
6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Business performance
6.4.BIOTRONIK, INC.
6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Key strategic moves and developments
6.5.BOSTON SCIENTIFIC CORPORATION
6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product Portfolio
6.5.5.Business performance
6.6.BECTON, DICKINSON AND COMPANY
6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio
6.6.5.Business performance
6.6.6.Key strategic moves and developments
6.7.CARDINAL HEALTH, INC.
6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.7.5.Business performance
6.8.COOK MEDICAL, INC.
6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Key strategic moves and developments
6.9.KONINKLIJKE PHILIPS N.V. (PHILIPS)
6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.9.5.Business performance
6.9.6.Key strategic moves and developments
6.10.TERUMO CORPORATION
6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio
6.10.5.Business performance
6.10.6.Key strategic moves and developments
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top winning strategies, 2019
3.3.Top player positioning
3.3.1.Top investment pockets
3.4.Key forces shaping peripheral artery disease industry/market
3.4.1.Drivers
3.4.1.1.Growth in geriatric population and increase in prevalence of peripheral artery disease
3.4.1.2.Introduction of advanced interventional products
3.4.1.3.Improvement of healthcare infrastructure in developing countries
3.4.1.4.Improved insurance and reimbursement policies
3.4.2.Restraints
3.4.2.1.Restenosis
3.4.2.2.Stringent approval process for stents
3.4.3.Opportunity
3.4.3.1.Market opportunities in developing countries
3.4.4.Impact Analysis
3.5.COVID-19 impact on the market
CHAPTER 4:PERIPHERAL ARTERY DISEASE MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast, by type
4.2.Peripheral Angioplasty Balloons
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Peripheral angioplasty balloons, by type
4.2.4.1.Market size and forecast
4.2.4.2.Old/normal balloons, market size and forecast
4.2.4.3.Cutting & scoring balloons, market size and forecast
4.2.4.4.Drug-coated balloons, market size and forecast
4.3.Peripheral Stents
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Peripheral stent, by type
4.3.4.1.Market size and forecast
4.3.4.2.Self-expandable, market size and forecast
4.3.4.3.Balloon-expandable, market size and forecast
4.3.4.4.Covered stents, market size and forecast
4.3.4.5.Drug-eluting stents, market size and forecast
4.4.Peripheral Catheters
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Peripheral catheters, by type
4.4.4.1.Market size and forecast
4.4.4.2.Angiography catheters, market size and forecast
4.4.4.3.Guiding catheters, market size and forecast
4.5.Inferior Vena Cava (IVC) Filters
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.5.4.Inferior vena cava (IVC) filters, by type
4.5.4.1.Market size and forecast
4.5.4.2.Permanent filters, market size and forecast
4.5.4.3.Retrievable filters, market size and forecast
4.6.Plaque Modification Devices
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
4.6.4.Plaque modification devices, by type
4.6.4.1.Market size and forecast
4.6.4.2.Thrombectomy devices, market size and forecast
4.6.4.3.Thrombectomy devices, By type
4.6.4.4.Thrombectomy devices, market size and forecast, by type
4.6.4.4.1.Mechanical thrombectomy devices, market size and forecast
4.6.4.4.2.Aspiration thrombectomy devices, market size and forecast
4.6.4.4.3.Rheolytic thrombectomy devices, market size and forecast
4.6.4.5.Atherectomy devices, market size and forecast
4.7.Hemodynamic Flow Alteration Devices
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market analysis, by country
4.7.4.Hemodynamic flow alteration devices, By type
4.7.4.1.Market size and forecast
4.7.4.2.Embolic protection devices, market size and forecast
4.7.4.3.Chronic total occlusion devices, market size and forecast
4.8.Peripheral Accessories
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.8.3.Market analysis, by country
4.8.4.Peripheral Accessories, By type
4.8.4.1.Market size and forecast
4.8.4.2.Peripheral vascular closure devices, market size and forecast
4.8.4.3.Introducer sheaths, market size and forecast
4.8.4.4.Guidewires, market size and forecast
4.8.4.5.Balloon inflation devices, market size and forecast
CHAPTER 5:PERIPHERAL ARTERY DISEASE MARKET, BY REGION
5.1.Overview
5.1.1.Market size and forecast, by region
5.2.North America
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country
5.2.3.Market size and forecast, by type
5.2.4.U.S.
5.2.5.Canada
5.2.6.Mexico
5.3.Europe
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country
5.3.3.Market size and forecast, by type
5.3.4.Germany
5.3.5.France
5.3.6.UK
5.3.7.Italy
5.3.8.Spain
5.3.9.Rest of Europe
5.4.Asia-Pacific
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country
5.4.3.Market size and forecast, by type
5.4.4.Japan
5.4.5.China
5.4.6.India
5.4.7.Australia
5.4.8.Rest of Asia-Pacific
5.5.LAMEA
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country
5.5.3.Market size and forecast, by type
5.5.4.Brazil
5.5.5.South Africa
5.5.6.Saudi Arabia
5.5.7.Rest of LAMEA
CHAPTER 6:COMPANY PROFILES
6.1.ABBOTT LABORATORIES
6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.2.ANGIODYNAMICS, INC.
6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.2.6.Key strategic moves and developments
6.3.B. BRAUN MELSUNGEN AG
6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Business performance
6.4.BIOTRONIK, INC.
6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Key strategic moves and developments
6.5.BOSTON SCIENTIFIC CORPORATION
6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product Portfolio
6.5.5.Business performance
6.6.BECTON, DICKINSON AND COMPANY
6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio
6.6.5.Business performance
6.6.6.Key strategic moves and developments
6.7.CARDINAL HEALTH, INC.
6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.7.5.Business performance
6.8.COOK MEDICAL, INC.
6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Key strategic moves and developments
6.9.KONINKLIJKE PHILIPS N.V. (PHILIPS)
6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.9.5.Business performance
6.9.6.Key strategic moves and developments
6.10.TERUMO CORPORATION
6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio
6.10.5.Business performance
6.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY REGION, 2019–2027 ($MILLION)
TABLE 07.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 10.PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 11.PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 12.PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 13.HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 15.PERIPHERAL ACCESSORIES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 16.PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 17.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 18.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.U.S. PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 20.CANADA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 22.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 23.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 24.GERMANY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 25.FRANCE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 26.UK PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 27.ITALY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 28.SPAIN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.REST OF EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 30.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 31.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 32.JAPAN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 33.CHINA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 34.INDIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 35.AUSTRALIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.REST OF ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 37.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 39.BRAZIL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 40.SOUTH AFRICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.SAUDI ARABIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 42.REST OF LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 43.ABBOTT: COMPANY SNAPSHOT
TABLE 44.ABBOTT: OERATING SEGMENT
TABLE 45.ABBOTT: PRODUCT PORTFOLIO
TABLE 46.ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 47.ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 48.ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 49.B. BRAUN: COMPANY SNAPSHOT
TABLE 50.B. BRAUN: OPERATING SEGMENTS
TABLE 51.B. BRAUN: PRODUCT PORTFOLIO:
TABLE 52.BIOTRONIK, INC..: COMPANY SNAPSHOT
TABLE 53.BIOTRONIK, INC..: OPERATING SEGMENTS
TABLE 54.BIOTRONIK, INC.: PRODUCT PORTFOLIO
TABLE 55.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 56.BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 57.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 58.BD: SNAPSHOT
TABLE 59.BD: OPERATING SEGMENTS
TABLE 60.BD: PRODUCT PORTFOLIO
TABLE 61.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 62.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 63.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 64.COOK: COMPANY SNAPSHOT
TABLE 65.COOK: OERATING SEGMENT
TABLE 66.COOK: PRODUCT PORTFOLIO
TABLE 67.PHILIPS: COMPANY SNAPSHOT
TABLE 68.PHILIPS: OPERATING SEGMENTS
TABLE 69.PHILIPS: PRODUCT PORTFOLIO
TABLE 70.TERUMO: COMPANY SNAPSHOT
TABLE 71.TERUMO: OPERATING SEGMENTS
TABLE 72.TERUMO: PRODUCT PORTFOLIO
TABLE 01.GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY REGION, 2019–2027 ($MILLION)
TABLE 07.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 10.PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 11.PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 12.PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 13.HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 15.PERIPHERAL ACCESSORIES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 16.PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 17.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 18.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.U.S. PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 20.CANADA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 22.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 23.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 24.GERMANY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 25.FRANCE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 26.UK PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 27.ITALY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 28.SPAIN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.REST OF EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 30.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 31.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 32.JAPAN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 33.CHINA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 34.INDIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 35.AUSTRALIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.REST OF ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 37.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 39.BRAZIL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 40.SOUTH AFRICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.SAUDI ARABIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 42.REST OF LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 43.ABBOTT: COMPANY SNAPSHOT
TABLE 44.ABBOTT: OERATING SEGMENT
TABLE 45.ABBOTT: PRODUCT PORTFOLIO
TABLE 46.ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 47.ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 48.ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 49.B. BRAUN: COMPANY SNAPSHOT
TABLE 50.B. BRAUN: OPERATING SEGMENTS
TABLE 51.B. BRAUN: PRODUCT PORTFOLIO:
TABLE 52.BIOTRONIK, INC..: COMPANY SNAPSHOT
TABLE 53.BIOTRONIK, INC..: OPERATING SEGMENTS
TABLE 54.BIOTRONIK, INC.: PRODUCT PORTFOLIO
TABLE 55.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 56.BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 57.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 58.BD: SNAPSHOT
TABLE 59.BD: OPERATING SEGMENTS
TABLE 60.BD: PRODUCT PORTFOLIO
TABLE 61.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 62.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 63.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 64.COOK: COMPANY SNAPSHOT
TABLE 65.COOK: OERATING SEGMENT
TABLE 66.COOK: PRODUCT PORTFOLIO
TABLE 67.PHILIPS: COMPANY SNAPSHOT
TABLE 68.PHILIPS: OPERATING SEGMENTS
TABLE 69.PHILIPS: PRODUCT PORTFOLIO
TABLE 70.TERUMO: COMPANY SNAPSHOT
TABLE 71.TERUMO: OPERATING SEGMENTS
TABLE 72.TERUMO: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.PERIPHERAL ARTERY DISEASE MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2018–2020*
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020*
FIGURE 04.TOP WINNING STRATEGIES: COMPANY, 2018–2020
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.TOP INVESTMENT POCKETS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH BARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTES
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.HIGH THREAT OF NEW ENTRANTS
FIGURE 12.IMPACT ANALYSIS, PERIPHERAL ARTERY DISEASE MARKET
FIGURE 13.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.GLOBAL OLD/NORMAL BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 15.GLOBAL CUTTING & SCORING BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 16.GLOBAL DRUG COATED BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.GLOBAL SELF-EXPANDABLE MARKET, 2019–2027 ($MILLION)
FIGURE 19.GLOBAL BALLOON EXPANDABLE MARKET, 2019–2027 ($MILLION)
FIGURE 20.GLOBAL COVERED STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 21.GLOBAL DRUG-ELUTING STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY COUNTRY, 2019 & 2027 (%)
FIGURE 23.GLOBAL ANGIOGRAPHY CATHETERS MARKET, 2019–2027 ($MILLION)
FIGURE 24.GLOBAL GUIDING CATHETERS MARKET, 2019–2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 26.GLOBAL PERMANENT FILTERS MARKET, 2019–2027 ($MILLION)
FIGURE 27.GLOBAL RETRIEVABLE FILTERS MARKET, 2019–2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 29.GLOBAL THROMBECTOMY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 30.GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
FIGURE 31.GLOBAL THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, BY TYPE 2019–2027 ($MILLION)
FIGURE 32.GLOBAL THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, BY TYPE 2019–2027 ($MILLION)
FIGURE 33.GLOBAL THROMBECTOMY DEVICES MARKET FOR RHEOLYTIC THROMBECTOMY DEVICES, BY TYPE, 2019–2027 ($MILLION)
FIGURE 34.GLOBAL ATHERECTOMY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 35.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 36.GLOBAL EMBOLIC PROTECTION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 37.GLOBAL CHRONIC TOTAL OCCLUSION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 38.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 39.GLOBAL PERIPHERAL VASCULAR CLOSURE DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 40.GLOBAL INTRODUCER SHEATHS MARKET, 2019–2027 ($MILLION)
FIGURE 41.GLOBAL GUIDEWIRES MARKET, 2019–2027 ($MILLION)
FIGURE 42.GLOBAL BALLOON INFLATION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 43.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 46.ANGIODYNAMICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.B. BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.B. BRAUN: REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 51.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.BOSTON SCIENTIFIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 53.BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2019 (%)
FIGURE 54.BOSTON SCIENTIFIC: NET SALES, BY REGION, 2019 (%)
FIGURE 55.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 57.BECTON, DICKINSON AND COMPANY REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 58.CARDINAL HEALTH: NET SALES, 2017–2019 ($MILLION)
FIGURE 59.CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 60.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 61.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 62.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 63.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 64.TERUMO CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 65.TERUMO: REVENUE SHARE, BY SEGMENTS, 2018(%)
FIGURE 66.TERUMO: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 01.PERIPHERAL ARTERY DISEASE MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2018–2020*
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020*
FIGURE 04.TOP WINNING STRATEGIES: COMPANY, 2018–2020
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.TOP INVESTMENT POCKETS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH BARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTES
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.HIGH THREAT OF NEW ENTRANTS
FIGURE 12.IMPACT ANALYSIS, PERIPHERAL ARTERY DISEASE MARKET
FIGURE 13.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.GLOBAL OLD/NORMAL BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 15.GLOBAL CUTTING & SCORING BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 16.GLOBAL DRUG COATED BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.GLOBAL SELF-EXPANDABLE MARKET, 2019–2027 ($MILLION)
FIGURE 19.GLOBAL BALLOON EXPANDABLE MARKET, 2019–2027 ($MILLION)
FIGURE 20.GLOBAL COVERED STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 21.GLOBAL DRUG-ELUTING STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY COUNTRY, 2019 & 2027 (%)
FIGURE 23.GLOBAL ANGIOGRAPHY CATHETERS MARKET, 2019–2027 ($MILLION)
FIGURE 24.GLOBAL GUIDING CATHETERS MARKET, 2019–2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 26.GLOBAL PERMANENT FILTERS MARKET, 2019–2027 ($MILLION)
FIGURE 27.GLOBAL RETRIEVABLE FILTERS MARKET, 2019–2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 29.GLOBAL THROMBECTOMY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 30.GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
FIGURE 31.GLOBAL THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, BY TYPE 2019–2027 ($MILLION)
FIGURE 32.GLOBAL THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, BY TYPE 2019–2027 ($MILLION)
FIGURE 33.GLOBAL THROMBECTOMY DEVICES MARKET FOR RHEOLYTIC THROMBECTOMY DEVICES, BY TYPE, 2019–2027 ($MILLION)
FIGURE 34.GLOBAL ATHERECTOMY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 35.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 36.GLOBAL EMBOLIC PROTECTION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 37.GLOBAL CHRONIC TOTAL OCCLUSION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 38.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 39.GLOBAL PERIPHERAL VASCULAR CLOSURE DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 40.GLOBAL INTRODUCER SHEATHS MARKET, 2019–2027 ($MILLION)
FIGURE 41.GLOBAL GUIDEWIRES MARKET, 2019–2027 ($MILLION)
FIGURE 42.GLOBAL BALLOON INFLATION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 43.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 46.ANGIODYNAMICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.B. BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.B. BRAUN: REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 51.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.BOSTON SCIENTIFIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 53.BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2019 (%)
FIGURE 54.BOSTON SCIENTIFIC: NET SALES, BY REGION, 2019 (%)
FIGURE 55.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 57.BECTON, DICKINSON AND COMPANY REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 58.CARDINAL HEALTH: NET SALES, 2017–2019 ($MILLION)
FIGURE 59.CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 60.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 61.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 62.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 63.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 64.TERUMO CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 65.TERUMO: REVENUE SHARE, BY SEGMENTS, 2018(%)
FIGURE 66.TERUMO: REVENUE SHARE, BY REGION, 2018 (%)
